Literature DB >> 12098049

Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis.

Wolfgang Schröder1, Stephan E Baldus, Stefan P Mönig, Tobias K E Beckurts, Hans P Dienes, Arnulf H Hölscher.   

Abstract

In patients with squamous cell carcinoma of the esophagus, the preoperative clinical staging of the N category is primarily based on the lymph node size. Lymph nodes > 10 mm are considered to be tumor-infiltrated. This histopathologic study investigated the correlation of lymph node size and metastatic infiltration in esophageal carcinoma of patients with and without neoadjuvant radiochemotherapy. The specimens of 40 patients with squamous cell carcinoma of the esophagus were included in a prospective morphometric study. Half of these patients (n = 20) received preoperative radiochemotherapy. The number of resected lymph nodes were counted, and the largest diameter of each node was measured. Metastatic involvement of each node was analyzed by histologic examination. The frequency of lymph node metastases was calculated and correlated to the lymph node size. A total of 1196 lymph nodes with an average of 29.9 nodes per patient were resected and analyzed; 129 lymph nodes (10.8%) showed metastatic infiltration. The average size of 1067 tumor-free lymph nodes was 5.1 +/- 3.8 mm in maximum diameter, whereas the average size of 129 metastatic lymph nodes was 6.7 +/- 4.2 mm (p = 0.00006). Of all resected lymph nodes, 761 (63.6%) were < or = 5 mm in maximum diameter. Only 9.3% (n = 111) of all resected lymph nodes were > 10 mm in maximum diameter. There was no significant correlation between lymph node size and the frequency of nodal metastases. No difference in size could be demonstrated between patients with and without neoadjuvant radiochemotherapy. Diagnostic imaging techniques using size as the criterion of nodal infiltration cannot exactly assess the nodal status of patients with esophageal carcinoma. This is also true for patients after neoadjuvant radiochemotherapy. Therefore, evaluation of the nodal status in patients with squamous cell carcinoma of the esophagus is entirely based on pathohistologic analysis after a well defined lymphadenectomy.

Entities:  

Mesh:

Year:  2002        PMID: 12098049     DOI: 10.1007/s00268-001-0271-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  [Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University].

Authors:  J R Siewert; H Bartels; E Bollschweiler; H J Dittler; U Fink; A H Hölscher; J D Roder
Journal:  Chirurg       Date:  1992-09       Impact factor: 0.955

2.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

Review 3.  Esophageal carcinoma: impact of staging on treatment.

Authors:  J R Siewert; H J Dittler
Journal:  Endoscopy       Date:  1993-01       Impact factor: 10.093

4.  Lymph node size and metastatic infiltration in colon cancer.

Authors:  S P Mönig; S E Baldus; T K Zirbes; W Schröder; D G Lindemann; H P Dienes; A H Hölscher
Journal:  Ann Surg Oncol       Date:  1999-09       Impact factor: 5.344

5.  Staging of gastric cancer: correlation of lymph node size and metastatic infiltration.

Authors:  S P Mönig; T K Zirbes; W Schröder; S E Baldus; D G Lindemann; H P Dienes; A H Hölscher
Journal:  AJR Am J Roentgenol       Date:  1999-08       Impact factor: 3.959

6.  Endosonography for preoperative staging of specific nodal groups associated with esophageal cancer.

Authors:  R Y Chandawarkar; T Kakegawa; H Fujita; H Yamana; Y Toh; H Fujitoh
Journal:  World J Surg       Date:  1996 Jul-Aug       Impact factor: 3.352

7.  Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging.

Authors:  K M Kerr; D Lamb; C G Wathen; W S Walker; N J Douglas
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 8.  Staging of squamous esophageal cancer: accuracy and value.

Authors:  A H Hölscher; H J Dittler; J R Siewert
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  Carcinoma of the esophagus: CT vs MR imaging in determining resectability.

Authors:  S Takashima; N Takeuchi; H Shiozaki; K Kobayashi; S Morimoto; J Ikezoe; N Tomiyama; K Harada; K Shogen; T Kozuka
Journal:  AJR Am J Roentgenol       Date:  1991-02       Impact factor: 3.959

10.  Ignoring small lymph nodes can be a major cause of staging error in gastric cancer.

Authors:  N Noda; M Sasako; N Yamaguchi; Y Nakanishi
Journal:  Br J Surg       Date:  1998-06       Impact factor: 6.939

View more
  21 in total

1.  Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit.

Authors:  Wolfgang Schröder; Arnulf H Hölscher; Marc Bludau; Daniel Vallböhmer; Elfriede Bollschweiler; Christian Gutschow
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 2.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

Review 3.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

4.  Limited resection for early esophageal cancer?

Authors:  W Schröder; C A Gutschow; A H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2003-04-01       Impact factor: 3.445

5.  Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio.

Authors:  Jianfang Liu; Zhu Wang; Huafei Shao; Dong Qu; Jian Liu; Libo Yao
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

6.  Thoracic lymph node delineation at dose-reduced (1 mSv) dose-modulated contrast enhanced MDCT: a retrospective pilot study.

Authors:  Marco Paolini; Kathrin Wirth; Amanda Tufman; Maximilian Reiser; Rudolf M Huber; Ullrich G Mueller-Lisse
Journal:  Radiol Med       Date:  2016-05-06       Impact factor: 3.469

7.  The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma.

Authors:  Ming-Qiu Chen; Cheng Chen; Hai-Jie Lu; Ben-Hua Xu
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

8.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer.

Authors:  Aine Sakurada; Taro Takahara; Thomas C Kwee; Tomohiro Yamashita; Seiji Nasu; Tomohiko Horie; Marc Van Cauteren; Yutaka Imai
Journal:  Eur Radiol       Date:  2009-01-27       Impact factor: 5.315

9.  Transthoracic esophagectomy after endoscopic mucosal resection in patients with early esophageal carcinoma.

Authors:  W Schröder; K Wirths; C Gutschow; D Vallböhmer; M Bludau; B Schumacher; H Neuhaus; A H Hölscher
Journal:  J Gastrointest Surg       Date:  2008-10-16       Impact factor: 3.452

10.  The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy?

Authors:  W Schröder; D Vallböhmer; M Bludau; A Banczyk; C Gutschow; A H Hölscher
Journal:  J Gastrointest Surg       Date:  2008-02-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.